APA način citiranja

Jim, H. S. L., Eisel, S. L., Hoogland, A. I., Shaw, S., King, J. C., & Dicker, A. P. (2020). Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors. Cancers (Basel).

Čikaški stil citiranja

Jim, Heather S. L., Sarah L. Eisel, Aasha I. Hoogland, Sandra Shaw, Jennifer C. King, i Adam P. Dicker. "Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors." Cancers (Basel) 2020.

MLA način citiranja

Jim, Heather S. L., et al. "Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors." Cancers (Basel) 2020.